FGF9 and neoplasm: Interestingly, FGFR1 signaling in DU 145 cells with the KLF5KR mutant was more sensitive to FGF9 (Figure 5G), implying that an endogenous pathway in the tumor cells could be involved in the activation of FGFR1 signaling.